Bluesight vs Plenful (2026)
Both automate hospital pharmacy back office work, and they reconcile different things. Bluesight's ControlCheck reconciles every controlled substance dispense against its administration, waste or return to find diversion, and its PrivacyPro product (formerly Protenus) watches for inappropriate record access. Plenful works the money side of pharmacy: it screens 340B claims for missed savings, automates rebate and Maximum Fair Price reconciliation, reconstructs uncoded referrals with language models, and automates intake and prior authorization for specialty pharmacy. A diversion or compliance problem points to Bluesight. A 340B savings or specialty intake problem points to Plenful.
- Automatic reconciliation of controlled substance transactions across cabinets, the record, wholesalers and the vault, which the company says covers 95 percent of transactions without manual review.
- Insider risk in one company: drug diversion and inappropriate access to patient records.
- Unlimited user seats, so cost does not grow with the number of pharmacists and investigators.
- 340B work end to end: claim screening, missed savings, rebate reporting and Maximum Fair Price reconciliation.
- A referral agent reads clinical notes to rebuild referrals that were never coded, recovering savings rules alone would miss.
- Named health system and infusion customers, with published results at Samaritan Health Services.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Bluesight and Plenful are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Bluesight | Plenful |
|---|---|---|
| Primary category | Healthcare Cybersecurity | Healthcare Administrative Automation |
| Founded | 2011 | Not recorded |
| Headquarters | Alexandria, Virginia, United States | San Francisco, California |
| Website | bluesight.com | plenful.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Plenful
-
EHR / interoperability
Cencora said it has combined its benefit verification and electronic prior authorization network with Plenful's automation platform, so health system pharmacy teams can check access, out of pocket costs, formulary and prior authorization in one workflow.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Medication and compliance intelligence company whose two surveillance products watch hospital staff for insider risk: ControlCheck, formerly Bluesight for Controlled Substances, for drug diversion, and PrivacyPro, formerly Protenus, for inappropriate access to patient records. Founded in 2011 as Kit Check, rebranded to Bluesight in December 2022, based in Alexandria, Virginia, led by co founder and chief executive Kevin MacDonald and backed by Thoma Bravo.
Source: AI Health Index, September 2026
Plenful automates pharmacy back-office work for health systems, specialty pharmacies and infusion teams, centered on the 340B drug pricing program. For covered entities it screens every 340B eligible claim, finds missed savings, automates rebate reporting and Maximum Fair Price reconciliation, and runs a Referral Agent that uses language models to read clinical notes and other record data, reconstruct referrals that were never coded, match them to claims and send referral documentation back to the referring provider.
Source: AI Health Index, September 2026
Questions buyers ask
How do Bluesight and Plenful handle patient data?
Bluesight states that Prism Assistant operates entirely within Bluesight's secure environment and draws only on data already integrated into ControlCheck, which answers where that assistant sends controlled substance and staff data. Beyond that the assurances are general: a HIPAA compliant cloud, an annual HIPAA examination, and website level safeguards.
The agreement says Plenful may use service data, including protected health information, to generate outputs, classifications and workflow actions for the customer, and "will not use PHI to train models for the benefit of other Plenful customers". From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 23, 2026. No vendor pays for placement.
How much do Bluesight and Plenful leave to the clinician?
In Bluesight's case, the company frames the product as an early warning system giving pharmacy directors control of discrepancy identification, with exception reports focusing attention on important discrepancies and automatic tracking of resolutions to produce a complete audit trail.
For Plenful, the Referral Agent page describes shifting 340B teams from manual search to targeted review of claims the model flags with high confidence, with referral documentation generated and sent back to the referring provider, so a person reviews what the model surfaces. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 23, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Plenful publishes its own miss rate alongside a claim to handle over 95 percent of the work, and it publishes no security attestation and nothing on where it runs. Bluesight names a security attestation but publishes no price, unit or contract shape.
Plenful's economics are framed as recovered savings, which invites a percentage of savings fee. Ask how that fee is calculated and audited before signing.